市場調査レポート

商品コード

1563126

放射線腫瘍の世界市場：タイプ・用途・エンドユーザー・地域別の予測 (～2032年)

Global Radiation Oncology Market Research Report Information by Type, By Application, By End-User And by Region -Forecast Till 2032

出版日: 2024年08月10日 | 発行: Market Research Future

| ページ情報: 英文 176 Pages | 納期: 即納可能

価格

PDF & Excel (Single User License)

USD 4,950 747,252円

レポートPDF、Excelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Multi User License)

USD 5,950 898,212円

レポートPDF、Excelを同一企業内の最大15名がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Enterprise License)

USD 7,250 1,094,460円

レポートPDF、Excelを同一企業内のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDF、Excelの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.96円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

放射線腫瘍の市場規模は、2023年の82億3,000万米ドル、2024年の89億米ドルから、予測期間中は8.0%のCAGRで推移し、2032年には165億1,000万米ドルの規模に成長すると予測されています。世界のがん罹患率の上昇と、手術や化学療法に加えて放射線腫瘍を含む併用療法が受け入れられつつあることが、市場拡大の原動力となっています。

人口の高齢化、ライフスタイルの変化、環境要因に起因する世界のがん罹患率の増加が同市場の主な牽引役となっています。強度変調放射線治療 (IMRT) 、定位放射線手術 (SRS) 、陽子線治療などの放射線治療における技術の進歩は、治療精度と患者の転帰を大幅に改善し、市場の成長を促進しています。さらに、化学療法や外科手術に加えて放射線腫瘍を含む併用療法の利用が増加していることも、患者により包括的で生産性の高い治療の選択肢を与えることで市場の拡大に貢献しています。

がんの罹患率の増加も放射線腫瘍の急成長の大きな原動力となっています。同市場は、がん罹患率の上昇に対応した効果的な代替治療に対する世界的な需要の高まりの結果として拡大しています。

地域別インサイト

北米地域は2023年にもっとも高い市場シェアを占め、予測期間中にCAGR 8.2％で成長し、2032年にはおよそ72億4,000万米ドルの規模に達すると予測されています。一方、アジア太平洋地域は予測期間中にもっとも高い8.4％のCAGRで発展すると予想されています。

北米の放射線腫瘍市場は、多くの地域特有の要因によって急速に拡大しています。北米におけるがん罹患率の増加は重要な決定要因です。ライフスタイルの変化や高齢化によりがんの罹患率が上昇すると、放射線腫瘍サービスに対する需要も増加します。

欧州の放射線腫瘍市場は、多くの地域特有の要因に牽引され、大きな成長を遂げようとしています。欧州全域におけるがん罹患率の増加は、重要な決定要因です。がん罹患率の増加により、放射線治療などの高度な治療技術に対する需要が高まっています。

アジア太平洋地域の放射線腫瘍市場は、地域特有のさまざまな理由に牽引され、大きな成長が見込まれています。アジア太平洋地域におけるがんの有病率の増加は重要な要因です。

当レポートでは、世界の放射線腫瘍の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

促進要因
- がんの発症率増加
- 放射線治療における技術的進歩
- 外科手術と化学療法に加え、放射線腫瘍を含む併用療法の採用が増加
課題
- 規制承認の課題
- 償還に関する懸念
- 技術を持つ放射線治療専門家の不足
機会
- 価値に基づく医療・治療ソリューションへの重点の高まり
- 放射線腫瘍の分野におけるAIと機械学習の利用の増加

第5章市場要因分析

バリューチェーン分析
ポーターのファイブフォース分析
COVID-19の影響分析

第6章世界の放射線腫瘍市場：タイプ別

外部放射線治療
- 線形加速器 (リニアック)
- コバルト60システム
- 粒子線治療システム
- 陽子線治療システム
内部放射線療法
- シード
- アフターローダー
- 術中放射線治療システム

第7章世界の放射線腫瘍市場：用途別

前立腺がん
乳がん
肺がん
頭・首のがん
その他

第8章世界の放射線腫瘍市場：エンドユーザー別

病院・クリニック
腫瘍センター
学術研究機関

第9章世界の放射線腫瘍市場：地域別

世界
北米
欧州
アジア太平洋
その他の地域

第10章競合情勢

競合ダッシュボード
市場シェア分析
開発件数でトップの企業
主要企業リスト：国別
比較分析：主要企業の財務動向
主な展開と成長戦略

第11章企業プロファイル

VARIAN MEDICAL SYSTEMS, INC.
ELEKTA
ACCURACY INCORPORATED
IBA RADIOPHARMA SOLUTIONS
BD
MEVION MEDICAL SYSTEMS
NORDION
NTP RADIOISOTOPES SOC LTD
CURIUM
REFLEXION

図表

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 5 GLOBAL RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 7 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 8 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 11 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 12 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 13 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 14 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 15 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 16 US RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 17 US RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 18 US RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 19 US RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 20 US RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 21 US RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 22 CANADA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 23 CANADA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 24 CANADA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 25 CANADA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 26 CANADA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 27 CANADA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 28 EUROPE RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 1 EUROPE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 2 EUROPE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 3 EUROPE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 4 EUROPE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 5 EUROPE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 EUROPE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 GERMANY RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 8 GERMANY RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 9 GERMANY RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 10 GERMANY RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 11 GERMANY RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 12 GERMANY RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 13 FRANCE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 14 FRANCE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 15 FRANCE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 16 FRANCE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 17 FRANCE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 FRANCE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 19 UK RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 20 UK RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 21 UK RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 22 UK RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 23 UK RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 24 UK RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 25 ITALY RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 26 ITALY RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 27 ITALY RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 28 ITALY RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 29 ITALY RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 30 ITALY RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 31 SPAIN RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 32 SPAIN RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 33 SPAIN RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 34 SPAIN RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 35 SPAIN RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 36 SPAIN RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 37 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 38 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 39 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 40 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 41 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 42 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 43 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 44 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 45 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 46 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 47 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 48 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 49 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 50 CHINA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 51 CHINA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 52 CHINA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 53 CHINA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 54 CHINA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 55 CHINA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 56 JAPAN RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 57 JAPAN RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 58 JAPAN RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 59 JAPAN RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 60 JAPAN RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 61 JAPAN RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 62 INDIA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 63 INDIA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 64 INDIA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 65 INDIA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 66 INDIA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 67 INDIA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 68 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 69 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 70 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 71 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 72 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 73 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 74 AUSTRALIA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 75 AUSTRALIA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 76 AUSTRALIA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 77 AUSTRALIA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 78 AUSTRALIA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 79 AUSTRALIA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 80 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 81 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 82 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 83 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 84 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 85 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 86 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 87 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 88 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 89 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 90 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 91 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 92 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 93 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 94 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 95 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 96 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 97 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 98 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 99 AFRICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 100 AFRICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 101 AFRICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 102 AFRICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 103 AFRICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 104 AFRICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 105 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 106 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 107 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
TABLE 108 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
TABLE 109 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 110 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 111 PRODUCT LAUNCH
TABLE 112 PARTNERSHIP & COLLABORATION
TABLE 113 EXPANSION & ACQUISITION
TABLE 114 INSTRUMENT
TABLE 115 VARIAN MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
TABLE 116 ELEKTA: PRODUCTS OFFERED
TABLE 117 ACCURACY INCORPORATED: PRODUCTS OFFERED
TABLE 118 ACCURACY INCORPORATED: KEY DEVELOPMENTS
TABLE 119 IBA RADIOPHARMA SOLUTIONS: PRODUCTS OFFERED
TABLE 120 IBA RADIOPHARMA SOLUTIONS: KEY DEVELOPMENTS
TABLE 121 BD: PRODUCTS OFFERED
TABLE 122 MEVION MEDICAL SYSTEMS: PRODUCTS OFFERED
TABLE 123 MEVION MEDICAL SYSTEMS: KEY DEVELOPMENTS
TABLE 124 NORDION: PRODUCTS OFFERED
TABLE 125 NTP RADIOISOTOPES SOC LTD: PRODUCTS OFFERED
TABLE 126 CURIUM: PRODUCTS OFFERED
TABLE 127 REFLEXION: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL RADIATION ONCOLOGY MARKET: STRUCTURE
FIGURE 2 GLOBAL RADIATION ONCOLOGY MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 SUPPLY CHAIN ANALYSIS: GLOBAL RADIATION ONCOLOGY MARKET
FIGURE 6 PORTER'S FIVE FORCES MODEL: GLOBAL RADIATION ONCOLOGY MARKET
FIGURE 7 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, SEGMENT ATTRACTIVENESS ANALYSIS
FIGURE 8 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, 2022 (% SHARE)
FIGURE 9 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, SEGMENT ATTRACTIVENESS ANALYSIS
FIGURE 10 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, 2022 (% SHARE)
FIGURE 11 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, SEGMENT ATTRACTIVENESS ANALYSIS
FIGURE 12 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, 2022 (% SHARE)
FIGURE 13 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION, 2022 (% SHARE)
FIGURE 14 NORTH AMERICA MARKET: SWOT ANALYSIS
FIGURE 15 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE)
FIGURE 16 EUROPE RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE)
FIGURE 17 EUROPE MARKET: SWOT ANALYSIS
FIGURE 18 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE)
FIGURE 19 ASIA PACIFIC MARKET: SWOT ANALYSIS
FIGURE 20 ROW RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE)
FIGURE 21 REST OF THE WORLD MARKET: SWOT ANALYSIS
FIGURE 22 COMPETITOR DASHBOARD: GLOBAL RADIATION ONCOLOGY MARKET
FIGURE 23 GLOBAL RADIATION ONCOLOGY MARKET: COMPETITIVE ANALYSIS, 2022
FIGURE 24 VARIAN MEDICAL SYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 VARIAN MEDICAL SYSTEMS, INC.: SWOT ANALYSIS
FIGURE 26 ELEKTA: SWOT ANALYSIS
FIGURE 27 ACCURACY INCORPORATED: SWOT ANALYSIS
FIGURE 28 IBA RADIOPHARMA SOLUTIONS: SWOT ANALYSIS
FIGURE 29 BD: SWOT ANALYSIS
FIGURE 30 MEVION MEDICAL SYSTEMS: SWOT ANALYSIS
FIGURE 31 NORDION: SWOT ANALYSIS
FIGURE 32 NTP RADIOISOTOPES SOC LTD: SWOT ANALYSIS
FIGURE 33 CURIUM: SWOT ANALYSIS
FIGURE 34 REFLEXION: SWOT ANALYSIS

Product Code: MRFR/Pharma/10828-CR

Global Radiation Oncology Market Research Report Information by Type (External Beam Radiation Therapy and Internal Radiation Therapy), By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck, and Others), By End-User (Hospitals & Clinics, Oncology Centers and Academic & Research Institutes) And by Region (North America, Europe, Asia-Pacific, and Rest of The World) -Forecast Till 2032

Market Overview

In 2023, the Radiation Oncology Market was valued at USD 8.23 billion. The market is expected to expand from USD 8.90 billion in 2024 to USD 16.51 billion by 2032, with a compound annual growth rate (CAGR) of 8.0% over the forecast period (2024-2032). The rising prevalence of cancer worldwide, as well as the growing acceptance of combination therapies that include radiation oncology in addition to surgery and chemotherapy, are driving market expansion.

The increased global prevalence of cancer, driven by aging populations, lifestyle changes, and environmental factors, is the primary driver of the radiation oncology industry. Technological advances in radiation therapy, including as intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), and proton therapy, have significantly improved treatment accuracy and patient outcomes, driving market growth. Furthermore, the growing use of combination therapies that include radiation oncology in addition to chemotherapy and surgery helps to expand the market by giving patients with more comprehensive and productive treatment options.

The rising incidence of cancer has emerged as a major impetus for the rapid growth of radiation oncology. The radiation oncology market is expanding as a result of rising global demand for effective treatment alternatives in response to cancer's increasing prevalence.

Market Segment insights

The Radiation Oncology Market is divided into two product types: external beam radiation therapy and internal beam radiation therapy.

The Radiation Oncology Market has been segmented by price range into Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, and Others.

The market has been divided into three segments based on the end user: hospitals and clinics, oncology centers, and academic and research institutions.

Regional insights

The Radiation Oncology Market has been classified by region: North America, Europe, Asia-Pacific, and the Rest of the World. North America held the highest market share in 2023 and is expected to reach roughly USD 7.24 billion by 2032, growing at an 8.2% CAGR over the forecast period. However, Asia-Pacific is expected to develop at the fastest CAGR of 8.4% over the projection period.

The radiation oncology market in North America is rapidly expanding, driven by a number of unique regional variables. The increased incidence of cancer in North America is a key determinant. As cancer incidence rises due to lifestyle changes and an aging population, so does the demand for radiation oncology services.

The radiation oncology market in Europe is poised for significant growth, driven by a number of regionally specific reasons. The increased cancer incidence across Europe is a key determinant. The increasing prevalence of cancer has created a greater demand for sophisticated therapeutic techniques, such as radiation therapy.

The radiation oncology market in the Asia Pacific area is expected to grow significantly, driven by a variety of region-specific reasons. The increasing prevalence of cancer in the Asia-Pacific area is a significant factor.

Major Players

Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuracy Incorporated (US), IBA Radiopharma Solutions (Belgium), BD (US), Mevion Medical Systems (US), Nordion (Canada), NTP Radioisotopes Soc Ltd. (South Africa), Curium (France), and Reflexion (US) are among the key players in the Radiation Oncology Market.

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 CONSUMPTION & NET TRADE APPROACH
- 3.6.2 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TECHNIQUE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 GROWING INCIDENCE OF CANCER
- 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN RADIATION THERAPY
- 4.2.3 RISING ADOPTION OF COMBINATION THERAPIES INVOLVING RADIATION ONCOLOGY ALONGSIDE SURGERY AND CHEMOTHERAPY
4.3 CHALLENGES
- 4.3.1 REGULATORY APPROVAL CHALLANGES
- 4.3.2 REIMBURSEMENT CONCERNS
- 4.3.3 LACK OF SKILLED RADIOTHERAPY PROFESSIONALS
4.4 OPPORTUNITY
- 4.4.1 GROWING EMPHASIS ON VALUE-BASED HEALTHCARE AND TREATMENT SOLUTIONS
- 4.4.2 RISING UTILIZATION OF ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING WITHIN THE FIELD OF RADIATION ONCOLOGY

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 PARTICIPANTS (AT DIFFERENT NODES)
  - 5.1.1.1 RAW MATERIAL SUPPLIERS
  - 5.1.1.2 MANUFACTURERS
  - 5.1.1.3 DISTRIBUTION CHANNEL
  - 5.1.1.4 END-USER
- 5.1.2 INTEGRATION LEVELS
- 5.1.3 KEY ISSUES ADDRESSED (KEY SUCCESS FACTORS)
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 BARGAINING POWER OF SUPPLIERS
- 5.2.2 BARGAINING POWER OF BUYERS
- 5.2.3 THREAT OF NEW ENTRANTS
- 5.2.4 THREAT OF SUBSTITUTES
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT ANALYSIS OF COVID-19
- 5.3.1 IMPACT ON OVERALL HEALTHCARE MARKET
  - 5.3.1.1 ECONOMIC IMPACT
- 5.3.2 IMPACT ON GLOBAL RADIATION ONCOLOGY MARKET
- 5.3.3 IMPACT ON MARKET DEMAND
  - 5.3.3.1 IMPACT DUE TO RESTRICTIONS/LOCKDOWN
  - 5.3.3.2 CONSUMER SENTIMENTS
- 5.3.4 IMPACT ON PRICING

6 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE

6.1 INTRODUCTION
6.2 EXTERNAL BEAM RADIATION THERAPY
- 6.2.1 LINEAR ACCELERATORS (LINAC)
  - 6.2.1.1 GAMMA KNIFE
  - 6.2.1.2 CYBERKNIFE
- 6.2.2 COBALT-60 SYSTEM
- 6.2.3 PARTICLE THERAPY SYSTEM
- 6.2.4 PROTON BEAM THERAPY SYSTEM
6.3 INTERNAL RADIATION THERAPY
- 6.3.1 SEEDS
- 6.3.2 AFTERLOADERS
- 6.3.3 INTRAOPERATIVE RADIOTHERAPY SYSTEMS

7 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 PROSTATE CANCER
7.3 BREAST CANCER
7.4 LUNG CANCER
7.5 HEAD & NECK
7.6 OTHERS

8 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER

8.1 INTRODUCTION
8.2 HOSPITALS & CLINICS
8.3 ONCOLOGY CENTERS
8.4 ACADEMIC & RESEARCH INSTITUTES

9 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION

9.1 OVERVIEW
9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.2 CANADA
9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 FRANCE
- 9.3.3 UK
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
- 9.4.1 CHINA
- 9.4.2 JAPAN
- 9.4.3 INDIA
- 9.4.4 SOUTH KOREA
- 9.4.5 AUSTRALIA
- 9.4.6 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
- 9.5.1 MIDDLE EAST
- 9.5.2 AFRICA
- 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION
10.2 COMPETITION DASHBOARD
- 10.2.1 PRODUCT PORTFOLIO
- 10.2.2 REGIONAL PRESENCE
- 10.2.3 STRATEGIC ALLIANCES
- 10.2.4 INDUSTRY EXPERIENCES
10.3 MARKET SHARE ANALYSIS, 2022
10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL RADIATION ONCOLOGY MARKET
10.5 LIST OF KEY PLAYERS, BY COUNTRY
10.6 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.7.1 PRODUCT LAUNCH
- 10.7.2 PARTNERSHIP & COLLABORATION
- 10.7.3 EXPANSION & ACQUISITION
- 10.7.4 INVESTMENT

11 COMPANY PROFILES

11.1 VARIAN MEDICAL SYSTEMS, INC.
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGY
11.2 ELEKTA
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 SWOT ANALYSIS
- 11.2.6 KEY STRATEGY
11.3 ACCURACY INCORPORATED
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 SWOT ANALYSIS
- 11.3.6 KEY STRATEGY
11.4 IBA RADIOPHARMA SOLUTIONS
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 SWOT ANALYSIS
- 11.4.6 KEY STRATEGY
11.5 BD
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS OFFERED
- 11.5.4 SWOT ANALYSIS
- 11.5.5 KEY STRATEGY
11.6 MEVION MEDICAL SYSTEMS
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 PRODUCTS OFFERED
- 11.6.3 KEY DEVELOPMENTS
- 11.6.4 SWOT ANALYSIS
- 11.6.5 KEY STRATEGY
11.7 NORDION
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGY
11.8 NTP RADIOISOTOPES SOC LTD
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 PRODUCTS OFFERED
- 11.8.3 KEY DEVELOPMENTS
- 11.8.4 SWOT ANALYSIS
- 11.8.5 KEY STRATEGY
11.9 CURIUM
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 PRODUCTS OFFERED
- 11.9.3 KEY DEVELOPMENTS
- 11.9.4 SWOT ANALYSIS
- 11.9.5 KEY STRATEGY
11.10 REFLEXION
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 PRODUCTS OFFERED
- 11.10.3 KEY DEVELOPMENTS
- 11.10.4 SWOT ANALYSIS
- 11.10.5 KEY STRATEGY

放射線腫瘍の世界市場：タイプ・用途・エンドユーザー・地域別の予測 (～2032年)

Global Radiation Oncology Market Research Report Information by Type, By Application, By End-User And by Region -Forecast Till 2032

目次

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場力学

第5章市場要因分析

第6章世界の放射線腫瘍市場：タイプ別

第7章世界の放射線腫瘍市場：用途別

第8章世界の放射線腫瘍市場：エンドユーザー別

第9章世界の放射線腫瘍市場：地域別

第10章競合情勢

第11章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Market Overview

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE

7 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION

8 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER

9 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILES

放射線腫瘍の世界市場：タイプ・用途・エンドユーザー・地域別の予測 (～2032年)

Global Radiation Oncology Market Research Report Information by Type, By Application, By End-User And by Region -Forecast Till 2032

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

第5章 市場要因分析

第6章 世界の放射線腫瘍市場：タイプ別

第7章 世界の放射線腫瘍市場：用途別

第8章 世界の放射線腫瘍市場：エンドユーザー別

第9章 世界の放射線腫瘍市場：地域別

第10章 競合情勢

第11章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Market Overview

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE

7 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION

8 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER

9 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILES

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場力学

第5章市場要因分析

第6章世界の放射線腫瘍市場：タイプ別

第7章世界の放射線腫瘍市場：用途別

第8章世界の放射線腫瘍市場：エンドユーザー別

第9章世界の放射線腫瘍市場：地域別

第10章競合情勢

第11章企業プロファイル